Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
02/15/2007 | WO2006067614B1 Heteroaromatic derivatives useful as anticancer agents |
02/15/2007 | WO2005123703A8 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
02/15/2007 | US20070037984 Biphenyl derivatives |
02/15/2007 | US20070037983 Phenanthroline derivative compound |
02/15/2007 | US20070037888 4-(Pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer |
02/15/2007 | US20070037845 Peptido-mimetic compounds containing rgd sequence useful as integrin inhibitors, and intermediates thereof |
02/15/2007 | US20070037843 Zolpidem hemitartrate |
02/15/2007 | US20070037841 Inhibitors |
02/15/2007 | US20070037840 Tricyclic benzimidazoles |
02/15/2007 | US20070037838 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d 6,5-d']dipyrimidyne and 10-aza-analogue thereof |
02/15/2007 | US20070037836 Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide |
02/15/2007 | US20070037834 Bicyclic pyrimidine derivatives |
02/15/2007 | US20070037827 Sirtuin modulating compounds |
02/15/2007 | US20070037823 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
02/15/2007 | US20070037805 Fused heteroaryl derivatives |
02/15/2007 | US20070037804 Imidazolone phenylalanine derivatives |
02/15/2007 | US20070037803 Benzimidazole derivatives |
02/15/2007 | DE102005038141A1 Substituierte 8-(3-Aminopropyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-on-Derivate Substituted 8- (3-aminopropyl) -1-phenyl-1,3,8-triaza-spiro [4.5] decan-4-one derivatives |
02/15/2007 | DE102005037499A1 Pyrazolderivate Pyrazole derivatives |
02/15/2007 | DE102005037406A1 Bi- to tetra-chromophore fluorescence dye where the displacement of the chromophore is adjusted to obtain hypsochrome chromatic distortion by H-type-interaction effect, useful as e.g. dye for inkjet printer paper dye |
02/15/2007 | CA2618524A1 Pyrazole derivatives having tyrosine kinase activity |
02/15/2007 | CA2618368A1 Imidazopyridine derivatives as sirtuin modulating agents |
02/15/2007 | CA2618165A1 Imidazopyridine derivatives as cannabinoid receptor ligands |
02/15/2007 | CA2617951A1 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
02/15/2007 | CA2617760A1 Pyrimidine compounds as serotonin receptor modulators |
02/15/2007 | CA2617473A1 Acylguanidine derivative or salt thereof |
02/15/2007 | CA2617293A1 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
02/15/2007 | CA2616020A1 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
02/15/2007 | CA2614156A1 Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents |
02/15/2007 | CA2605481A1 Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections |
02/14/2007 | EP1752456A1 Corneal perception recovery drug containing amide compound |
02/14/2007 | EP1752455A2 Chemokine receptor binding heterocyclic compounds |
02/14/2007 | EP1751165A1 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones |
02/14/2007 | EP1751157A1 Inhibitors of the hiv integrase enzyme |
02/14/2007 | EP1751156A1 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents |
02/14/2007 | EP1751155A1 Substituted azachinazolines having an antiviral action |
02/14/2007 | EP1751154A1 5-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b] indol-2-ones and analogs as anti-virals |
02/14/2007 | EP1751153A1 Hetaryloxy-substituted phenylamino pyrimidines as rho kinase inhibitors |
02/14/2007 | EP1751152A2 Azinyl imidazoazine and azinyl carboxamide |
02/14/2007 | EP1751151A1 Pyrazolo '3,4-b! pyridine compounds, and their use as phosphodiesterase type 4 (pde4) inhibitors |
02/14/2007 | EP1751142A1 Pyrimidines derivatives for the treatment of abnormal cell growth |
02/14/2007 | EP1751136A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
02/14/2007 | EP1751130A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
02/14/2007 | EP1751119A1 Novel fused heterocycles and uses thereof |
02/14/2007 | EP1751110A1 Method for the production of a-chloroalkylpyridyl ketones and/or the hydrochlorides thereof |
02/14/2007 | EP1751108A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
02/14/2007 | EP1750704A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
02/14/2007 | EP1651640B1 Nicotinamide derivatives useful as pde4 inhibitors |
02/14/2007 | EP1575948B1 Pyridodiazines as plant fungicides |
02/14/2007 | EP1562944B1 Pyrazoloquinolines with immunomodulating activity |
02/14/2007 | EP1560828B9 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
02/14/2007 | EP1551835B1 Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
02/14/2007 | EP1395586B1 Method for the production of zolpidem |
02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
02/14/2007 | EP1341790B1 Sulfonamido ether substituted imidazoquinolines |
02/14/2007 | EP1299378B1 Tetrahydropyridino or piperidino heterocyclic derivatives |
02/14/2007 | EP1294715B1 Quinazoline ditosylate salt compounds |
02/14/2007 | CN1914209A Diaza- or thiazadione derivatives with neuroprotective activity |
02/14/2007 | CN1914207A Azepinoindole derivatives as pharmaceutical agents |
02/14/2007 | CN1914206A 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments |
02/14/2007 | CN1914205A Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
02/14/2007 | CN1914204A Naphthyridine derivatives and their use as modulators of muscarinic receptors |
02/14/2007 | CN1914203A Sulfone substituted imidazo ring ethers |
02/14/2007 | CN1914193A Heterocyclic anti-migraine agents |
02/14/2007 | CN1913901A Diazabicyclic aryl derivatives as cholinergic receptor modulators |
02/14/2007 | CN1913778A Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
02/14/2007 | CN1911928A Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics |
02/14/2007 | CN1300141C Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors |
02/14/2007 | CN1300140C Compound of quinacridones-carbazole group and application in organic electroluminescence device |
02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
02/13/2007 | US7176322 Bone disorders; hyperparathyroidism; such as N-((1-ethyl-3-phenyl-1H-indol-5-yl)methyl)-1-phenylethanamine |
02/13/2007 | US7176313 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance |
02/13/2007 | US7176306 Hydroxyalkyl cyclic diamine compound |
02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
02/13/2007 | US7176220 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
02/13/2007 | US7176217 such as N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl]-2-azabicyclo[2.2.1]heptane-3-carboxamide, used in cosmetics or drugs as gelatinase inhibitors, for preventing skin aging or wrinkling; preventing diseases due to abnormal metabolism of tissue matrices such as arthritis, ulcers, metastasis or tumors |
02/13/2007 | US7176216 Antagonist for corticotropin-releasing factor receptors |
02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
02/13/2007 | US7176214 Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
02/13/2007 | US7176200 Derivatives of sulphonamides, their preparation and use as medicaments |
02/13/2007 | US7176198 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
02/13/2007 | US7175958 Electrophotographic photoconductor, process for forming an image, image forming apparatus and process cartridge for the same |
02/13/2007 | CA2254759C Inhibitors of prenyl transferases |
02/08/2007 | WO2007016525A2 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
02/08/2007 | WO2007016353A2 Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists |
02/08/2007 | WO2007016029A2 Diazepinoquinolines, synthesis thereof, and intermediates thereto |
02/08/2007 | WO2007015866A2 Inhibitors of p38 kinase and methods of treating inflammatory disorders |
02/08/2007 | WO2007015812A2 Hiv reverse transcriptase inhibitors |
02/08/2007 | WO2007014707A1 Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents |
02/08/2007 | WO2007014608A1 Quadratic acid ii derivatives |
02/08/2007 | WO2006110477A3 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
02/08/2007 | WO2006021307A8 Method for producing quaterrylene-3,4:13,14-tetracarboxy diimides by direct synthesis |
02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
02/08/2007 | US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
02/08/2007 | US20070032528 inhibitors of vascular endothelial growth factor receptor tyrosine kinase; antiproliferative agents; antitumor; 4-Hydroxy-3-(5-methylbenzimidazol-2-yl)hydropyridino[3,4-b]pyridin-2-one; nitrogen containing cyclic compounds |